Top Insights
Down 99%, biotech firm 180 Life Sciences pivots to crypto with ETH bet
The Nasdaq-listed biotechnology firm is raising $425 million for its ETH strategy, joining a parade of penny stocks investing in cryptocurrencies as their business flounders.
Related Articles
Trump announces 10% tariff on Denmark and key European allies over Greenland dispute
The tariffs could strain US-European relations, potentially impacting global trade dynamics and...
AI bots are betting billions on the future, but (no one knows if) they’re cheating | Opinion
Autonomous trading AI agents now dominate prediction markets, but the infrastructure to...
Saylor Defends Bitcoin Treasury Firms Amid Rising Criticism
Strategy chairman Michael Saylor pushed back on critics who say companies that...
Bitcoin ETFs turn red after four days of inflows, post $394.68M outflow
Bitcoin ETFs recorded $394.68 million in net outflows on January 16, ending...
Leave a comment